COVID-19

WELL Health Provides a Capital Allocation Update Reflecting the Addition of $100M in Annualized Revenue from Acquisitions Completed Since December 2024

WELL completed seven acquisitions since December 2024 across its Canadian Clinics, WELLSTAR and WELL USA business units, collectively representing total…

1 year ago

Australia’s Digital Health Evolution: 2025 EHR Vendor Rankings Highlight Progress, Innovation, and User Satisfaction in Healthcare IT, Black Book Research

NORTH SYDNEY, AU / ACCESSWIRE / January 14, 2025 / Black Book Research, a leading independent market research firm specializing…

1 year ago

mctlaw Files Federal Takings Claim on Behalf of Small Business Landlord for Losses During CDC’s Eviction Moratorium

Washington, D.C.--(Newsfile Corp. - January 13, 2025) - mctlaw has filed a lawsuit in the United States Court of Federal…

1 year ago

Hemostemix Settlement via Depository Trust Company Plus OTCQB Update

Calgary, Alberta--(Newsfile Corp. - January 13, 2025) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")…

1 year ago

Moderna Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference

Achieved 2024 product sales of $3.0 to 3.1 billion (unaudited) and an ending cash balance of approximately $9.5 billion (unaudited)Updates…

1 year ago

NanoViricides to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025

SHELTON, CT / ACCESSWIRE / January 13, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing…

1 year ago

Vaso Corporation Announces Executive Leadership Appointments & Names New Vice Chairman to the Board of Directors

PLAINVIEW, N.Y, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leader in human capital, information technology…

1 year ago

VIVUS Shares Progress on Pipeline and Key Program Milestones During the 43rd Annual J.P. Morgan Healthcare Conference 2025

CAMPBELL, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of…

1 year ago

Scilex Holding Company Announces Pain Medicine News Published Retrospective Claims Data on ZTlido® vs. Lidocaine 5% Patch

More patients treated with ZTlido® saw either a decrease or discontinuation of opioid use compared with those treated with the…

1 year ago